SPTX

18.1450.96%
DZ

Daphne Zohar

Founder, CEO, President & Director

Ms. Daphne Zohar serves as Founder of Seaport Therapeutics, Inc. and serves as its Chief Executive Officer & Director from April 09, 2024 and serves as its President since April 09, 2024. She Founded PureTech Health plc and served as its Chief Executive Officer, Managing Partner and Executive Director since 2015 until April 08, 2024 and served as its Senior Advisor & Board Observer since April 08, 2024 until 2025. Ms. Zohar co-founded Tal Medical, Inc. in 2010. She was a Director of resTORbio, Inc. since December 2017 until November 5, 2018. She is the Founder of Peerin and serves as its Chief Executive Officer. She served as a Director at Sonde Health Inc. Ms. Zohar serves as Founding Chief Executive Officer of Mandara Sciences, LLC. She served as a Director at Karuna Therapeutics, Inc. She served as Acting Chief Executive Officer of Vedanta Biosciences, Inc. Ms. Zohar is the Founder of Akili Interactive Labs, Inc. and served as its Chief Executive Officer. She co-founded Follica, Inc. in 2005 and served as its Founding Chief Executive Officer until May 13, 2009. She is the Founder of Satori Pharmaceuticals Incorporated and served as its Interim Chief Executive Officer until January 8, 2009. She served as the Chief Executive Officer at Solace Pharmaceuticals, Inc. until May 14, 2007. She was Founder and Managing Partner of Karuna Pharmaceuticals Inc. and is Director. Ms. Zohar’s career has focused on early stage venture creation and prior to her focus on life sciences, she was the Founder of several companies in diverse industries including EQ Inc. Zeta Ltd. which achieved leadership in the Israeli market and was subsequently sold to one of Israel's largest food companies and Kicks Inc. She serves as a Director of Tal Medical, Inc. Ms. Zohar serves as a Director of Follica, Inc. Enlight Biosciences LLC and PureTech Ventures. She sits on the Boards of Akili Interactive Labs Inc. The Sync Project, Vedanta Bioscience, Mandara Sciences, Neovasc Medical and Satori Pharmaceuticals Incorporated and is a Member of the Board of Associates of the WhiteHead Institute. She also sits on the Technology Development Fund Advisory Board at Children's Hospital Boston and is an Editorial Advisor to Xconomy. She served as a Director of Karuna Pharmaceuticals Inc. Endra, Inc. (ENDRA Life Sciences Inc.) and Solace Pharmaceuticals, Inc. She is also a sucessful entrepreneur. She is a Member of the Distinguished Faculty of the Biotechnology and the Ethical Imagination Global Summit organised by the Emory University Center for Ethics. She was recognized by Fierce Biotech as one of the “Top 10 Women in Biotech,” BioWorld as one of 28 leaders predicted to be the “movers and shakers” of the biotechnology industry and by the Boston Globe as one of the “Top 15 Innovators. Ms. Zohar has also co-founded and sits on the Board of Directors of a number of private life science companies. Ms. Zohar has been recognized as a top leader and innovator in biotechnology by a number of sources such as Scientific American. In 2003, she was named one of the world's top young innovators by MIT's Technology Review Magazine and one of the top ‘40 under 40’ by the Boston Business Journal. Ms. Zohar has been an entrepreneur since an early age and received her B.A. in entrepreneurship and new venture creation from College of Business Administration, Northeastern University. Ms. Zohar attended the exclusive Tefen Entrepreneurial College in Israel. Ms. Zohar received a B.S. from Northeastern University.

Positions